Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_assertion type Assertion NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_head.
- NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_assertion description "[p57KIP2 was weakly expressed in 4/6 glioblastoma (GBM) specimens by western blot/immunoreactivity was positive in 8/40 GBMs, and was primarily nuclear in location/motility of glioma cells was significantly reduced after p57KIP2 induction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_provenance.
- NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_assertion evidence source_evidence_literature NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_provenance.
- NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_assertion SIO_000772 15332324 NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_provenance.
- NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_assertion wasDerivedFrom lhgdn-20090331 NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_provenance.
- NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_assertion wasGeneratedBy ECO_0000203 NP182732.RA9zAv6jsFjknEUXQiKV6zOaGseWhmI4P8E-VCwfmMi9A130_provenance.